One of the interesting features of EBV-positive DLBCL is that 63–100% of ABC DLBCL patients are positive for IRF/MUM1, while being negative for CD10 and BCL6 [6,45]. This evidence concerns the gene MME and diffuse large B-cell lymphoma.